Tag Archives: Merck

Novartis takes total control of Alcon

In a $28Bn USD operation, the Swiss Pharmaceutical buys the 52% of Alcon’s remanent stock from Nestlé. Novartis would own an approximate 77 percent interest in Alcon. The operation goes at least one and a half year earlier than estimated in … Continue reading

Posted in Alta Dirección, Mercadotecnia, Salud | Tagged , , , , , , , , , , , , , , | Leave a comment

Abbott buys Solvay Pharma Division on $7Bn USD

According to information published today at the Wall Street Journal, Abbott will buy Solvay’s Pharmaceutical Division in a $7Bn USD deal. The official communication could be published by both companies as early as monday morning. With this deal Abbott is … Continue reading

Posted in Alta Dirección, Mercadotecnia, Ventas | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

Pharma: Trust Deficit or the Biggest Image Problem ever faced?

  It was  Saturday afternoon; April 4th, to be precise. 7-time Tour de France winner and full-time cancer fighter: Lance Armstrong was in his born-state Texas, riding to give a speech in the PhRMA meeting in San Antonio. From his … Continue reading

Posted in Alta Dirección, Mercadotecnia, Opinión, Salud, Ventas | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 3 Comments

2009 Pharma Mergers. A comprehensive analysis facing the future.

The last two months have been full of surprises in the Pharmaceutical arena. January was not even ending, when Pfizer was announcing its intentions of taking over Wyeth. Just some days after a month later and after a more-than-nervous weekend, … Continue reading

Posted in Alta Dirección, Mercadotecnia, Opinión, Salud, Ventas | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 3 Comments

La FDA anuncia medicamentos (literalmente).

Mucho se ha hablado sobre la publicidad de medicamentos y sus ventajas y desventajas de que esta sea abierta al público.  Para los defensores de la no publicidad abierta sobre productos éticos (fracciones I-IV), el mito de “evitar la auto-prescripción” … Continue reading

Posted in Mercadotecnia, Multimedia, Opinión | Tagged , , , , , , , , , , | Leave a comment